Citichem India Ltd vs Saroja Pharma Industries India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Citichem India Ltd is ₹ 14.9 as of 23 Mar 15:30 . The P/E Ratio of Citichem India Ltd changed from 14 on March 2025 to 14 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Saroja Pharma Industries India Ltd changed from 16.1 on March 2024 to 14.7 on March 2025 . This represents a CAGR of -4.45% over 2 years The Market Cap of Citichem India Ltd changed from ₹ 17.25 crore on March 2025 to ₹ 17.25 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 14.11 crore on March 2024 to ₹ 15.18 crore on March 2025 . This represents a CAGR of 3.72% over 2 years The Revenue of Citichem India Ltd is ₹ 1.49 crore as of Jun '24 .The Revenue of Saroja Pharma Industries India Ltd is ₹ 0 crore as of Jun '24 . The EBITDA of Citichem India Ltd is ₹ 0.28 crore as of Jun '24 .The EBITDA of Saroja Pharma Industries India Ltd is ₹ 0 crore as of Jun '24 . The Net Profit of Citichem India Ltd is ₹ 0.2 crore as of Jun '24 .The Net Profit of Saroja Pharma Industries India Ltd is ₹ 0 crore as of Jun '24 . The Dividend Payout of Citichem India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Citichem India Ltd

Citichem India Limited was incorporated as Citichem Alkalies (Bombay) Private Limited' dated March 18, 1992 at Maharashtra.
Further, Company was converted into public limited company and consequently name of Company was changed to Citichem Alkalies (Bombay) Limited' dated March 23, 1999.
Thereafter, the Company was further changed from Citichem Alkalies (Bombay) Limited' to Citichem India Ltd' pursuant to fresh certificate of incorporation dated April 17, 1999, issued by Registrar of Companies, Maharashtra.
Company made a fresh issue of 18,00,000 Equity Shares of Rs 10/- by raising funds through IPO aggregating up to Rs. 12.6 Cr in December, 2024. Citichem India Limited is one of the largest distributor of Industrial Chemicals.
The Company has wide applications in Textile & Garments, Pharmaceuticals, Finished Formulations, Key Starting Materials for API, Bulk Drugs and Intermediates, Paints, Coatings, Food, Fragrance & Perfumes, Pesticides and Agro Chemicals.

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

FAQs for the comparison of Citichem India Ltd and Saroja Pharma Industries India Ltd

Which company has a larger market capitalization, Citichem India Ltd or Saroja Pharma Industries India Ltd?

Market cap of Citichem India Ltd is 9 Cr while Market cap of Saroja Pharma Industries India Ltd is 11 Cr

What are the key factors driving the stock performance of Citichem India Ltd and Saroja Pharma Industries India Ltd?

The stock performance of Citichem India Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Citichem India Ltd and Saroja Pharma Industries India Ltd?

As of March 23, 2026, the Citichem India Ltd stock price is INR ₹14.1. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹28.15.

How do dividend payouts of Citichem India Ltd and Saroja Pharma Industries India Ltd compare?

To compare the dividend payouts of Citichem India Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.